Search Results - David Chardin
- Showing 1 - 4 results of 4
-
1
Total metabolic tumor volume on 18F-FDG PET/CT is a game-changer for patients with metastatic lung cancer treated with immunotherapy by Nicolas Martin, Pierre Tricarico, David Chardin, Sara Contu, Florent Hugonnet, Josiane Otto, Olivier Humbert
Published in Journal for ImmunoTherapy of Cancer (2024-04-01)Get full text
Article -
2
Primal-dual for classification with rejection (PD-CR): a novel method for classification and feature selection—an application in metabolomics studies by David Chardin, Olivier Humbert, Caroline Bailleux, Fanny Burel-Vandenbos, Valerie Rigau, Thierry Pourcher, Michel Barlaud
Published in BMC Bioinformatics (2021-12-01)Get full text
Article -
3
Survival analysis of patient groups defined by unsupervised machine learning clustering methods based on patient metabolomic data. by Caroline Bailleux, David Chardin, Jean-Marie Guigonis, Jean-Marc Ferrero, Yann Chateau, Olivier Humbert, Thierry Pourcher, Jocelyn Gal
Published in Computational and Structural Biotechnology Journal (2023-01-01)Get full text
Article -
4
Baseline metabolic tumor volume as a strong predictive and prognostic biomarker in patients with non-small cell lung cancer treated with PD1 inhibitors: a prospective study by Marius Ilie, Jonathan Benzaquen, Jacques Darcourt, Nicolas Martin, David Chardin, Josiane Otto, Olivier Humbert, Marie Paquet, Renaud Schiappa, Caroline Bailleux, Michel Poudenx, Aurélie Sciazza
Published in Journal for ImmunoTherapy of Cancer (2020-10-01)Get full text
Article
